These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Angiogenic Growth Factors for Coronary Artery Disease: Current Status and Prospects. Guo M; Shi JH; Wang PL; Shi DZ J Cardiovasc Pharmacol Ther; 2018 Mar; 23(2):130-141. PubMed ID: 29025278 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic angiogenesis for the management of refractory angina: current concepts. Attanasio S; Schaer G Cardiovasc Ther; 2011 Dec; 29(6):e1-e11. PubMed ID: 20406245 [TBL] [Abstract][Full Text] [Related]
4. High-dose plasmid-mediated VEGF gene transfer is safe in patients with severe ischemic heart disease (Genesis-I). A phase I, open-label, two-year follow-up trial. Favaloro L; Diez M; Mendiz O; Janavel GV; Valdivieso L; Ratto R; Garelli G; Salmo F; Criscuolo M; Bercovich A; Crottogini A Catheter Cardiovasc Interv; 2013 Nov; 82(6):899-906. PubMed ID: 22777825 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic angiogenesis: a new treatment approach for ischemic heart disease--part I. Ahn A; Frishman WH; Gutwein A; Passeri J; Nelson M Cardiol Rev; 2008; 16(4):163-71. PubMed ID: 18562806 [TBL] [Abstract][Full Text] [Related]
6. [Therapeutic revascularization in patients with advanced coronary heart disease. Rush or hope?]. Kipshidze NN; Kipshidze NN; Johnson WD Ter Arkh; 1999; 71(9):33-8. PubMed ID: 10553623 [No Abstract] [Full Text] [Related]
7. The vasculature: a therapeutic target in heart failure? Luxán G; Dimmeler S Cardiovasc Res; 2022 Jan; 118(1):53-64. PubMed ID: 33620071 [TBL] [Abstract][Full Text] [Related]
8. Calpain inhibition improves collateral-dependent perfusion in a hypercholesterolemic swine model of chronic myocardial ischemia. Sabe AA; Potz BA; Elmadhun NY; Liu Y; Feng J; Abid MR; Abbott JD; Senger DR; Sellke FW J Thorac Cardiovasc Surg; 2016 Jan; 151(1):245-52. PubMed ID: 26478238 [TBL] [Abstract][Full Text] [Related]